INOVIO PHARMACEUTICALS, INC. cotiza a 1.00 USD y tiene una capitalización bursátil de $103M. En los últimos 12 meses ha facturado $0 con un margen de flujo de caja libre del -136074.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely d…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.31 | $-0.28 | $-0.87 | $-0.61 |
| Estimado | $-0.33 | $-0.34 | $-0.48 | $-0.62 |
| Sorpresa | +6.1% | +17.6% | -81.3% | +1.6% |
| Métrica | INO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -132871.3% | -38.6% | -132832.7% |
| Net Margin | -130000.0% | -33.6% | -129966.4% |
| FCF Margin | -136074.5% | -13.9% | -136060.6% |
| ROE | -352.5% | -40.4% | -312.1% |
| ROA | -114.3% | -32.0% | -82.3% |
| Current Ratio | 1.40 | 2.84 | -1.44 |
| Debt / Equity | — | 0.28 | — |